Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Change in Account Payables (2020 - 2025)

Vivos Therapeutics has reported Change in Account Payables over the past 6 years, most recently at -$424000.0 for Q4 2025.

  • Quarterly Change in Account Payables fell 2027.27% to -$424000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $524000.0 through Dec 2025, up 150.0% year-over-year, with the annual reading at $524000.0 for FY2025, 150.0% up from the prior year.
  • Change in Account Payables was -$424000.0 for Q4 2025 at Vivos Therapeutics, down from $340000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $902000.0 in Q3 2021 and troughed at -$1.4 million in Q1 2021.
  • The 5-year median for Change in Account Payables is $156500.0 (2023), against an average of $42000.0.
  • Year-over-year, Change in Account Payables soared 321.43% in 2024 and then tumbled 2027.27% in 2025.
  • A 5-year view of Change in Account Payables shows it stood at $220000.0 in 2021, then skyrocketed by 248.64% to $767000.0 in 2022, then decreased by 19.69% to $616000.0 in 2023, then tumbled by 96.43% to $22000.0 in 2024, then tumbled by 2027.27% to -$424000.0 in 2025.
  • Per Business Quant, the three most recent readings for VVOS's Change in Account Payables are -$424000.0 (Q4 2025), $340000.0 (Q3 2025), and $499000.0 (Q2 2025).